KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Equity Ratio (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Equity Ratio readings, the most recent being 0.45 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 12.62% to 0.45 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.45, a 12.62% decrease, with the full-year FY2025 number at 0.45, down 12.62% from a year prior.
  • Equity Ratio hit 0.45 in Q4 2025 for Ginkgo Bioworks Holdings, down from 0.47 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.79 in Q2 2022 to a low of 0.21 in Q2 2021.
  • Median Equity Ratio over the past 5 years was 0.62 (2023), compared with a mean of 0.58.
  • Biggest five-year swings in Equity Ratio: skyrocketed 282.47% in 2022 and later fell 21.86% in 2024.
  • Ginkgo Bioworks Holdings' Equity Ratio stood at 0.76 in 2021, then fell by 9.65% to 0.68 in 2022, then dropped by 3.65% to 0.66 in 2023, then dropped by 21.09% to 0.52 in 2024, then fell by 12.62% to 0.45 in 2025.
  • The last three reported values for Equity Ratio were 0.45 (Q4 2025), 0.47 (Q3 2025), and 0.5 (Q2 2025) per Business Quant data.